	Glycemia	CT	HDL-c	Triglycerides	CT/HDL-c	TG/HDL
Sex
Male (n = 17)	0.82 ± 0.25	149.48 ± 43.87	36.68 ± 11.35	98.11 ± 65.96	4.45 ± 2.01	3.43 ± 3.31
Female (n = 33)	0.88 ± 0.38^ns	152.70 ± 42.05^ns	38.57 ± 10.57^ns	99.06 ± 67.35^ns	4.16 ± 1.39^ns	2.75 ± 2.01^ns
IMC (kg/m²)
<25 (n = 16)	0.81 ± 0.26	149.37 ± 42.94	36.87 ± 11.37	96.37 ± 64.98	4.42 ± 1.97	1.54 ± 1.21
≥25 (n = 34)	0.87 ± 0.34^ns	150.60 ± 42.97^ns	37.04 ± 11.14^ns	99.74 ± 68.18^b	4.41 ± 1.91^ns	3.69 ± 2.74^a
Smoking status
Yes (n = 3)	0.82 ± 0.28	150.82 ± 45.46	35.76 ± 11.4 3	97.18 ± 68.88	4.62 ± 2.10	3.10 ± 2.80
No (n = 47)	0.88 ± 0.34^ns	150.30 ± 43.36^ns	37.26 ± 11.15^ns	99.14 ± 68.67^ns	4.37 ± 1.91^ns	2.96 ± 2.58^ns
Alcohol status
Yes (n = 9)	0.91 ± 0.29	150.86 ± 44.13	37.58 ± 10.22	98.68 ± 68.80	4.31 ± 1.82	2.88 ± 2.41
No (n = 41)	0.86 ± 0.34^ns	150.31 ± 42.58^ns	36.89 ± 11.07^ns	98.89 ± 67.75^ns	4.41 ± 1.89^ns	2.98± 2.55^ns
PAD (mm Hg)
75 - 89 (n = 35)	0.86 ± 0.34	150.31 ± 42.58	36.89 ± 11.07	98.89 ± 67.75	4.41 ± 1.89	2.98 ± 2.55
<75 (n = 9)	0.91 ± 0.29^ns	150.86 ± 44.13^ns	37.58 ± 10.22^ns	98.68 ± 68.80^ns	4.31 ± 1.82^ns	2.87 ± 2.30^ns
≥90 (n = 6)	0.81 ± 0.27^ns	151.56 ± 43.88^ns	36.39 ± 11.05^ns	99.21 ± 66.11^ns	4.55 ± 2.02^ns	2.72 ± 2.70^ns
Therapeutic option
Monotherapy (n = 28)	0.88 ± 0.34	150.30 ± 43.37	37.26 ± 11.15	99.14 ± 68.76	4.37 ± 1.92	2.97 ± 2.58
Dual therapy (n = 22)	0.83 ± 0.33^ns	150.30 ± 43.02^ns	37.00 ± 11.16^ns	100.58 ± 67.38^ns	4.40 ± 1.91^ns	3.04 ± 2.55^ns
Duration of treatment
<5 years (n = 36)	0.84 ± 0.32	148.12 ± 42.75	36.74 ± 11.73	103.71 ± 70.69	4.41 ± 2.00	3.19 ± 2.74
≥5 years (n = 14)	0.86 ± 0.34^ns	150.31 ± 42.58^ns	36.89 ± 11.07^ns	98.89 ± 67.75^ns	4.41 ± 1.89^ns	2.98 ± 2.55^ns